Although we're heading into the summer doldrums, it proved to be a relatively big week for FDA. In the wake of President Obama signing MDUFA legislation, a contributing analyst for Forbes questioned the efficacy of user fees and noted that they didn't seem to be improving productivity at the agency. FDA this week also outlined plans for providing early feedback on products as part of the new "Pre-Sub" program aimed at helping manufacturers to improve effectiveness of their premarket submissions. Read about these and other top stories from around the Web in our weekly roundup.

• President Signs Legislation on Device, Drug Company User Fees (Bloomberg)
• User Fees for Medical Devices: Third Time Lucky? (Forbes)
• FDA Outlines Plans to Provide Earlier Feedback on Device Product Submissions (FDA)
• SEC Charges Orthofix International with FCPA Violations (SEC)
• Will Medtronic One Day Be Known as a Diagnostics, Population Management Company? (MedCity News)
• Joint Down, Spine Up: Trends in Orthopedics (MassDevice)
• mHealth Forecast: Increasing 'Clouds' with the Chance of Progress (MPMN)
• Massachusetts Eases Ban on Gifts from Medical Device Manufacturers (MD+DI)
• MedStartr, a Kickstarter for Medicine, Launches Today (MedGadget)